Table of Contents Author Guidelines Submit a Manuscript
Pulmonary Medicine
Volume 2015 (2015), Article ID 835204, 13 pages
http://dx.doi.org/10.1155/2015/835204
Review Article

Statins in Asthma: Potential Beneficial Effects and Limitations

1Department of Pharmacology, Kasturba Medical College, Manipal University, Manipal 576104, India
2Department of Pulmonary Medicine, Kasturba Medical College, Manipal University, Manipal 576104, India

Received 31 July 2015; Revised 2 October 2015; Accepted 18 October 2015

Academic Editor: Andrew J. Halayko

Copyright © 2015 Dipanjan Bhattacharjee et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Endo, “A historical perspective on the discovery of statins,” Proceedings of the Japan Academy, Series B: Physical and Biological Sciences, vol. 86, no. 5, pp. 484–493, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. B. Chogtu, R. Magazine, and K. L. Bairy, “Statin use and risk of diabetes mellitus,” World Journal of Diabetes, vol. 6, no. 2, pp. 352–357, 2015. View at Publisher · View at Google Scholar
  3. L. Manniche, Sacred Luxuries: Fragrance, Aromatherapy, and Cosmetics in Ancient Egypt, Cornell University Press, New York, NY, USA, 1999.
  4. http://www.medicalnewstoday.com/info/asthma/asthma-history.php.
  5. F. H. Bosworth, “Hay fever, asthma, and allied affections,” Transactions of the American Clinical and Climatological Association, vol. 2, pp. 151–170, 1886. View at Google Scholar
  6. M. Opolski and I. Wilson, “Asthma and depression: a pragmatic review of the literature and recommendations for future research,” Clinical Practice and Epidemiology in Mental Health, vol. 1, article 18, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. World Health Organization. Media Centre, “Bronchial Asthma,” 2015, http://www.who.int/mediacentre/factsheets/fs206/en.
  8. W. T. Gerthoffer, J. Solway, and B. Camoretti-Mercado, “Emerging targets for novel therapy of asthma,” Current Opinion in Pharmacology, vol. 13, no. 3, pp. 324–330, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. A. A. Zeki, J. M. Bratt, M. Rabowsky, J. A. Last, and N. J. Kenyon, “Simvastatin inhibits goblet cell hyperplasia and lung arginase in a mouse model of allergic asthma: a novel treatment for airway remodeling?” Translational Research, vol. 156, no. 6, pp. 335–349, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. B. B. Davis, A. A. Zeki, J. M. Bratt et al., “Simvastatin inhibits smoke-induced airway epithelial injury: implications for COPD therapy,” European Respiratory Journal, vol. 42, no. 2, pp. 350–361, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. N. A. Turner, D. J. O'Regan, S. G. Ball, and K. E. Porter, “Simvastatin inhibits MMP-9 secretion from human saphenous vein smooth muscle cells by inhibiting the RhoA/ROCK pathway and reducing MMP-9 mRNA levels,” The FASEB Journal, vol. 19, no. 7, pp. 804–806, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. D. Schaafsma, G. Dueck, S. Ghavami et al., “The mevalonate cascade as a target to suppress extracellular matrix synthesis by human airway smooth muscle,” American Journal of Respiratory Cell and Molecular Biology, vol. 44, no. 3, pp. 394–403, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. V. Capra and G. E. Rovati, “Rosuvastatin inhibits human airway smooth muscle cells mitogenic response to eicosanoid contractile agents,” Pulmonary Pharmacology and Therapeutics, vol. 27, no. 1, pp. 10–16, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. N. Takeda, M. Kondo, S. Ito, Y. Ito, K. Shimokata, and H. Kume, “Role of RhoA inactivation in reduced cell proliferation of human airway smooth muscle by simvastatin,” American Journal of Respiratory Cell and Molecular Biology, vol. 35, no. 6, pp. 722–729, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. R. Madonna, P. Di Napoli, M. Massaro et al., “Simvastatin attenuates expression of cytokine-inducible nitric-oxide synthase in embryonic cardiac myoblasts,” The Journal of Biological Chemistry, vol. 280, no. 14, pp. 13503–13511, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. K.-C. Huang, C.-W. Chen, J.-C. Chen, and W.-W. Lin, “HMG-CoA reductase inhibitors inhibit inducible nitric oxide synthase gene expression in macrophages,” Journal of Biomedical Science, vol. 10, no. 4, pp. 396–405, 2003. View at Publisher · View at Google Scholar · View at Scopus
  17. T. Ahmad, U. Mabalirajan, A. Sharma et al., “Simvastatin improves epithelial dysfunction and airway hyperresponsiveness,” American Journal of Respiratory Cell and Molecular Biology, vol. 44, no. 4, pp. 531–539, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. C.-J. Liou, P.-Y. Cheng, W.-C. Huang et al., “Oral lovastatin attenuates airway inflammation and mucus secretion in ovalbumin-induced murine model of asthma,” Allergy, Asthma & Immunology Research, vol. 6, no. 6, pp. 548–557, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. W. Wang, W. Le, R. Ahuja, D.-Y. Cho, P. H. Hwang, and D. Upadhyay, “Inhibition of inflammatory mediators: role of statins in airway inflammation,” Otolaryngology: Head and Neck Surgery, vol. 144, no. 6, pp. 982–987, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. J. Liu, D. Suh, E. Yang, S. Lee, H. Park, and Y. S. Shin, “Attenuation of airway inflammation by simvastatin and the implications for asthma treatment: is the jury still out?” Experimental & Molecular Medicine, vol. 46, no. 9, article e113, 2014. View at Publisher · View at Google Scholar
  21. P. A. Beckett and P. H. Howarth, “Pharmacotherapy and airway remodelling in asthma?” Thorax, vol. 58, no. 2, pp. 163–174, 2003. View at Publisher · View at Google Scholar · View at Scopus
  22. C. Bergeron, M. K. Tulic, and Q. Hamid, “Airway remodelling in asthma: from benchside to clinical practice,” Canadian Respiratory Journal, vol. 17, no. 4, pp. e85–e94, 2010. View at Google Scholar · View at Scopus
  23. Y.-J. Chen, P. Chen, H.-X. Wang et al., “Simvastatin attenuates acrolein-induced mucin production in rats: involvement of the Ras/extracellular signal-regulated kinase pathway,” International Immunopharmacology, vol. 10, no. 6, pp. 685–693, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. C. Persson, “Simvastatin inhibits smoke-induced airway epithelial injury: implications for COPD therapy,” European Respiratory Journal, vol. 43, p. 1211, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. A. A. Zeki, P. Thai, N. J. Kenyon, and R. Wu, “Differential effects of simvastatin on IL-13-induced cytokine gene expression in primary mouse tracheal epithelial cells,” Respiratory Research, vol. 13, article 38, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. D. M. Murphy, I. A. Forrest, P. A. Corris et al., “Simvastatin attenuates release of neutrophilic and remodeling factors from primary bronchial epithelial cells derived from stable lung transplant recipients,” American Journal of Physiology—Lung Cellular and Molecular Physiology, vol. 294, no. 3, pp. L592–L599, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. W. R. Roche, J. Williams, R. Beasley, and S. Holgate, “Subepithelial fibrosis in the bronchi of asthmatics,” The Lancet, vol. 333, no. 8637, pp. 520–524, 1989. View at Publisher · View at Google Scholar · View at Scopus
  28. J. Huang, R. Olivenstein, R. Taha, Q. Hamid, and M. Ludwig, “Enhanced proteoglycan deposition in the airway wall of atopic asthmatics,” American Journal of Respiratory and Critical Care Medicine, vol. 160, no. 2, pp. 725–729, 1999. View at Publisher · View at Google Scholar · View at Scopus
  29. J. W. Wilson and X. Li, “The measurement of reticular basement membrane and submucosal collagen in the asthmatic airway,” Clinical and Experimental Allergy, vol. 27, no. 4, pp. 363–371, 1997. View at Publisher · View at Google Scholar · View at Scopus
  30. R. Suzuki, T. Kato, Y. Miyazaki et al., “Matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in sputum from patients with bronchial asthma,” Journal of Asthma, vol. 38, no. 6, pp. 477–484, 2001. View at Publisher · View at Google Scholar · View at Scopus
  31. C. Johnson and Z. S. Galis, “Matrix metalloproteinase-2 and −9 differentially regulate smooth muscle cell migration and cell-mediated collagen organization,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 24, no. 1, pp. 54–60, 2004. View at Publisher · View at Google Scholar · View at Scopus
  32. C. Johnson, H.-J. Sung, S. M. Lessner, M. E. Fini, and Z. S. Galis, “Matrix metalloproteinase-9 is required for adequate angiogenic revascularization of ischemic tissues. Potential role in capillary branching,” Circulation Research, vol. 94, no. 2, pp. 262–268, 2004. View at Publisher · View at Google Scholar · View at Scopus
  33. S. Ghavami, M. M. Mutawe, P. Sharma et al., “Mevalonate cascade regulation of airway mesenchymal cell autophagy and apoptosis: a dual role for p53,” PLoS ONE, vol. 6, no. 1, Article ID e16523, 2011. View at Publisher · View at Google Scholar · View at Scopus
  34. U. Schönbeck and P. Libby, “Inflammation, immunity, and HMG-CoA reductase inhibitors: statins as antiinflammatory agents?” Circulation, vol. 109, no. 21, supplement 1, pp. II18–II26, 2004. View at Google Scholar · View at Scopus
  35. D. Voet and J. G. Voet, “Lipids and membranes,” in Biochemistry, pp. 315–316, John Wiley & Sons, New York, NY, USA, 2nd edition, 1995. View at Google Scholar
  36. C. Stancu and A. Sima, “Statins: mechanism of action and effects,” Journal of Cellular and Molecular Medicine, vol. 5, no. 4, pp. 378–387, 2001. View at Publisher · View at Google Scholar · View at Scopus
  37. K. Wennerberg, K. L. Rossman, and C. J. Der, “The Ras superfamily at a glance,” Journal of Cell Science, vol. 118, no. 5, pp. 843–846, 2005. View at Publisher · View at Google Scholar · View at Scopus
  38. G. Pfitzer, “Regulation of myosin phosphorylation in smooth muscle,” Journal of Applied Physiology, vol. 91, no. 1, pp. 497–503, 2001. View at Google Scholar · View at Scopus
  39. A. P. Somlyo and A. V. Somlyo, “Ca2+ sensitivity of smooth muscle and nonmuscle myosin II: modulated by G proteins, kinases, and myosin phosphatase,” Physiological Reviews, vol. 83, no. 4, pp. 1325–1358, 2003. View at Publisher · View at Google Scholar · View at Scopus
  40. M. Amano, M. Ito, K. Kimura et al., “Phosphorylation and activation of myosin by Rho-associated kinase (Rho-kinase),” The Journal of Biological Chemistry, vol. 271, no. 34, pp. 20246–20249, 1996. View at Publisher · View at Google Scholar · View at Scopus
  41. M. Koyama, M. Ito, J. Feng et al., “Phosphorylation of CPI-17, an inhibitory phosphoprotein of smooth muscle myosin phosphatase, by Rho-kinase,” FEBS Letters, vol. 475, no. 3, pp. 197–200, 2000. View at Publisher · View at Google Scholar · View at Scopus
  42. T. Kaneko, M. Amano, A. Maeda et al., “Identification of calponin as a novel substrate of Rho-kinase,” Biochemical and Biophysical Research Communications, vol. 273, no. 1, pp. 110–116, 2000. View at Publisher · View at Google Scholar · View at Scopus
  43. D. D. Tang, W. Zhang, and S. J. Gunst, “The adapter protein CrkII regulates neuronal Wiskott-Aldrich syndrome protein, actin polymerization, and tension development during contractile stimulation of smooth muscle,” Journal of Biological Chemistry, vol. 280, no. 24, pp. 23380–23389, 2005. View at Publisher · View at Google Scholar · View at Scopus
  44. W. Zhang, Y. Wu, L. Du, D. D. Tang, and S. J. Gunst, “Activation of the Arp2/3 complex by N-WASp is required for actin polymerization and contraction in smooth muscle,” American Journal of Physiology—Cell Physiology, vol. 288, no. 5, pp. C1145–C1160, 2005. View at Publisher · View at Google Scholar · View at Scopus
  45. Y. Chiba, Y. Takada, S. Miyamoto, M. Mitsui-Saito, H. Karaki, and M. Misawa, “Augmented acetylcholine-induced, Rho-mediated Ca2+ sensitization of bronchial smooth muscle contraction in antigen-induced airway hyperresponsive rats,” British Journal of Pharmacology, vol. 127, no. 3, pp. 597–600, 1999. View at Publisher · View at Google Scholar · View at Scopus
  46. K. Iizuka, Y. Shimizu, H. Tsukagoshi et al., “Evaluation of Y-27632, a rho-kinase inhibitor, as a bronchodilator in guinea pigs,” European Journal of Pharmacology, vol. 406, no. 2, pp. 273–279, 2000. View at Publisher · View at Google Scholar · View at Scopus
  47. Y. Chiba, H. Sakai, and M. Misawa, “Augmented acetylcholine-induced translocation of RhoA in bronchial smooth muscle from antigen-induced airway hyper responsive rats,” British Journal of Pharmacology, vol. 133, no. 6, pp. 886–890, 2001. View at Publisher · View at Google Scholar · View at Scopus
  48. Y. Chiba and M. Misawa, “Increased expression of G12 and G13 proteins in bronchial smooth muscle of airway hyperresponsive rats,” Inflammation Research, vol. 50, no. 6, pp. 333–336, 2001. View at Publisher · View at Google Scholar · View at Scopus
  49. B. Camoretti-Mercado, H.-W. Liu, A. J. Halayko et al., “Physiological control of smooth muscle-specific gene expression through regulated nuclear translocation of serum response factor,” Journal of Biological Chemistry, vol. 275, no. 39, pp. 30387–30393, 2000. View at Publisher · View at Google Scholar · View at Scopus
  50. H. W. Liu, A. J. Halayko, D. J. Fernandes et al., “The RhoA/Rho kinase pathway regulates nuclear localization of serum response factor,” American Journal of Respiratory Cell and Molecular Biology, vol. 29, no. 1, pp. 39–47, 2003. View at Publisher · View at Google Scholar · View at Scopus
  51. G. K. Owens, M. S. Kumar, and B. R. Wamhoff, “Molecular regulation of vascular smooth muscle cell differentiation in development and disease,” Physiological Reviews, vol. 84, no. 3, pp. 767–801, 2004. View at Publisher · View at Google Scholar · View at Scopus
  52. J. Solway, S. M. Forsythe, A. J. Halayko, J. E. Vieira, M. B. Hershenson, and B. Camoretti-Mercado, “Transcriptional regulation of smooth muscle contractile apparatus expression,” American Journal of Respiratory and Critical Care Medicine, vol. 158, pp. S100–S108, 1998. View at Publisher · View at Google Scholar · View at Scopus
  53. C. P. Mack, A. V. Somlyo, M. Hautmann, A. P. Somlyo, and G. K. Owens, “Smooth muscle differentiation marker gene expression is regulated by Rhoa-mediated actin polymerization,” The Journal of Biological Chemistry, vol. 276, no. 1, pp. 341–347, 2001. View at Publisher · View at Google Scholar · View at Scopus
  54. F. Miralles, G. Posern, A.-I. Zaromytidou, and R. Treisman, “Actin dynamics control SRF activity by regulation of its coactivator MAL,” Cell, vol. 113, no. 3, pp. 329–342, 2003. View at Publisher · View at Google Scholar · View at Scopus
  55. M. Kamiyama, K. Utsunomiya, K. Taniguchi et al., “Contribution of Rho A and Rho kinase to platelet-derived growth factor-BB-induced proliferation of vascular smooth muscle cells,” Journal of Atherosclerosis and Thrombosis, vol. 10, no. 2, pp. 117–123, 2003. View at Publisher · View at Google Scholar · View at Scopus
  56. T. L. Ediger, N. A. Schulte, T. J. Murphy, and M. L. Toews, “Transcription factor activation and mitogenic synergism in airway smooth muscle cells,” European Respiratory Journal, vol. 21, no. 5, pp. 759–769, 2003. View at Publisher · View at Google Scholar · View at Scopus
  57. Y. Liu, Y. J. Suzuki, R. M. Day, and B. L. Fanburg, “Rho kinase-induced nuclear translocation of ERK1/ERK2 in smooth muscle cell mitogenesis caused by serotonin,” Circulation Research, vol. 95, no. 6, pp. 579–586, 2004. View at Publisher · View at Google Scholar · View at Scopus
  58. F. Nishiguchi, R. Fukui, M. Hoshiga et al., “Different migratory and proliferative properties of smooth muscle cells of coronary and femoral artery,” Atherosclerosis, vol. 171, no. 1, pp. 39–47, 2003. View at Publisher · View at Google Scholar · View at Scopus
  59. F. Matsumura, S. Ono, Y. Yamakita, G. Totsukawa, and S. Yamashiro, “Specific localization of serine 19 phosphorylated myosin II during cell locomotion and mitosis of cultured cells,” Journal of Cell Biology, vol. 140, no. 1, pp. 119–129, 1998. View at Publisher · View at Google Scholar · View at Scopus
  60. E. T. Naureckas, I. M. Ndukwu, A. J. Halayko, C. Maxwell, M. B. Hershenson, and J. Solway, “Bronchoalveolar lavage fluid from asthmatic subjects is mitogenic for human airway smooth muscle,” American Journal of Respiratory and Critical Care Medicine, vol. 160, no. 6, pp. 2062–2066, 1999. View at Publisher · View at Google Scholar · View at Scopus
  61. K. Page, J. Li, and M. B. Hershenson, “Platelet-derived growth factor stimulation of mitogen-activated protein kinases and cyclin D1 promoter activity in cultured airway smooth-muscle cells. Role of Ras,” American Journal of Respiratory Cell and Molecular Biology, vol. 20, no. 6, pp. 1294–1302, 1999. View at Publisher · View at Google Scholar · View at Scopus
  62. P. Vichi, A. Whelchel, H. Knot, M. Nelson, W. Kolch, and J. Posada, “Endothelin-stimulated ERK activation in airway smooth-muscle cells requires calcium influx and RaF activation,” American Journal of Respiratory Cell and Molecular Biology, vol. 20, no. 1, pp. 99–105, 1999. View at Publisher · View at Google Scholar · View at Scopus
  63. G. Damera and R. A. Panettieri Jr., “Does airway smooth muscle express an inflammatory phenotype in asthma?” British Journal of Pharmacology, vol. 163, no. 1, pp. 68–80, 2011. View at Publisher · View at Google Scholar · View at Scopus
  64. D. H. Yates, “Role of exhaled nitric oxide in asthma,” Immunology and Cell Biology, vol. 79, no. 2, pp. 178–190, 2001. View at Publisher · View at Google Scholar · View at Scopus
  65. S. Moncada and A. Higgs, “The L-arginine-nitric oxide pathway,” The New England Journal of Medicine, vol. 329, no. 27, pp. 2002–2012, 1993. View at Publisher · View at Google Scholar · View at Scopus
  66. R. Kishen and B. J. Pleuvry, “Some actions of sodium nitroprusside and glyceryl trinitrate on guinea-pig isolated trachealis muscle,” Journal of Pharmacy and Pharmacology, vol. 37, no. 7, pp. 502–504, 1985. View at Publisher · View at Google Scholar · View at Scopus
  67. F. P. Nijkamp and G. Folkerts, “Nitric oxide and bronchial reactivity,” Clinical and Experimental Allergy, vol. 24, no. 10, pp. 905–914, 1994. View at Publisher · View at Google Scholar · View at Scopus
  68. P. M. Dupuy, S. A. Shore, J. M. Drazen, C. Frostell, W. A. Hill, and W. M. Zapol, “Bronchodilator action of inhaled nitric oxide in guinea pigs,” Journal of Clinical Investigation, vol. 90, no. 2, pp. 421–428, 1992. View at Publisher · View at Google Scholar · View at Scopus
  69. M. Högman, C. Frostell, H. Arnberg, and G. Hedenstierna, “Inhalation of nitric oxide modulates methacholine-induced bronchoconstriction in the rabbit,” European Respiratory Journal, vol. 6, no. 2, pp. 177–180, 1993. View at Google Scholar · View at Scopus
  70. K. Alving, C. Fornhem, E. Weitzberg, and J. M. Lundberg, “Nitric oxide mediates cigarette smoke-induced vasodilatory responses in the lung,” Acta Physiologica Scandinavica, vol. 146, no. 3, pp. 407–408, 1992. View at Publisher · View at Google Scholar · View at Scopus
  71. A. Ialenti, A. Ianaro, S. Moncada, and M. Di Rosa, “Modulation of acute inflammation by endogenous nitric oxide,” European Journal of Pharmacology, vol. 211, no. 2, pp. 177–182, 1992. View at Publisher · View at Google Scholar · View at Scopus
  72. J. S. Erjefält, I. Erjefält, F. Sundler, and C. G. A. Persson, “Mucosal nitric oxide may tonically suppress airways plasma exudation,” American Journal of Respiratory and Critical Care Medicine, vol. 150, no. 1, pp. 227–232, 1994. View at Publisher · View at Google Scholar · View at Scopus
  73. C. M. Hart, “Nitric oxide in adult lung disease,” Chest, vol. 115, no. 5, pp. 1407–1417, 1999. View at Publisher · View at Google Scholar · View at Scopus
  74. J. O. N. Lundberg, E. Weitzberg, S. L. Nordvall, R. Kuylenstierna, J. M. Lundberg, and K. Alving, “Primarily nasal origin of exhaled nitric oxide and absence in Kartagener's syndrome,” European Respiratory Journal, vol. 7, no. 8, pp. 1501–1504, 1994. View at Publisher · View at Google Scholar · View at Scopus
  75. L. P. Ho, J. A. Innes, and A. P. Greening, “Nitrite levels in breath condensate of patients with cystic fibrosis is elevated in contrast to exhaled nitric oxide,” Thorax, vol. 53, no. 8, pp. 680–684, 1998. View at Publisher · View at Google Scholar · View at Scopus
  76. R. Iyengar, D. J. Stuehr, and M. A. Marletta, “Macrophage synthesis of nitrite, nitrate, and N-nitrosamines: precursors and role of the respiratory burst,” Proceedings of the National Academy of Sciences of the United States of America, vol. 84, no. 18, pp. 6369–6373, 1987. View at Publisher · View at Google Scholar · View at Scopus
  77. M. Watanabe and S. Kakuta, “Expression and localization of the inducible isoform of nitric oxide synthase in nasal polyps,” Journal of Otolaryngology of Japan, vol. 105, no. 8, pp. 873–881, 2002. View at Google Scholar · View at Scopus
  78. T. B. McCall, R. M. J. Palmer, and S. Moncada, “Induction of nitric oxide synthase in rat peritoneal neutrophils and its inhibition by dexamethasone,” European Journal of Immunology, vol. 21, no. 10, pp. 2523–2527, 1991. View at Publisher · View at Google Scholar · View at Scopus
  79. G. A. Cerchiaro, C. Scavone, S. Texeira, and P. Sannomiya, “Inducible nitric oxide synthase in rat neutrophils: role of insulin,” Biochemical Pharmacology, vol. 62, no. 3, pp. 357–362, 2001. View at Publisher · View at Google Scholar · View at Scopus
  80. G. Cirino, S. Fiorucci, and W. C. Sessa, “Endothelial nitric oxide synthase: the Cinderella of inflammation?” Trends in Pharmacological Sciences, vol. 24, no. 2, pp. 91–95, 2003. View at Publisher · View at Google Scholar · View at Scopus
  81. S. Cook, P. Vollenweider, B. Ménard, M. Egli, P. Nicod, and U. Scherrer, “Increased eNO and pulmonary iNOS expression in eNOS null mice,” European Respiratory Journal, vol. 21, no. 5, pp. 770–773, 2003. View at Publisher · View at Google Scholar · View at Scopus
  82. H. E. Marshall and J. S. Stamler, “Inhibition of NF-κB by S-nitrosylation,” Biochemistry, vol. 40, no. 6, pp. 1688–1693, 2001. View at Publisher · View at Google Scholar · View at Scopus
  83. R. Ten Broeke, R. De Crom, R. Van Haperen et al., “Overexpression of endothelial nitric oxide synthase suppresses features of allergic asthma in mice,” Respiratory Research, vol. 7, article 58, 2006. View at Publisher · View at Google Scholar · View at Scopus
  84. M. J. Thomassen, L. T. Buhrow, M. J. Connors, F. T. Kaneko, S. C. Erzurum, and M. S. Kavuru, “Nitric oxide inhibits inflammatory cytokine production by human alveolar macrophages,” American Journal of Respiratory Cell and Molecular Biology, vol. 17, no. 3, pp. 279–283, 1997. View at Publisher · View at Google Scholar · View at Scopus
  85. J. G. Filep, B. Battistini, and P. Sirois, “Induction by endothelin-1 of epithelium-dependent relaxation of guinea-pig trachea in vitro: role for nitric oxide,” British Journal of Pharmacology, vol. 109, no. 3, pp. 637–644, 1993. View at Publisher · View at Google Scholar · View at Scopus
  86. M. Figini, C. Emanueli, C. Bertrand, P. Javdan, and P. Geppetti, “Evidence that tachykinins relax the guinea-pig trachea via nitric oxide release and by stimulation of a septide-insensitive NK1 receptor,” British Journal of Pharmacology, vol. 117, no. 6, pp. 1270–1276, 1996. View at Publisher · View at Google Scholar · View at Scopus
  87. H. Ninomiya, Y. Uchida, T. Endo et al., “The effects of calcitonin gene-related peptide on tracheal smooth muscle of guinea-pigs in vitro,” British Journal of Pharmacology, vol. 119, no. 7, pp. 1341–1346, 1996. View at Publisher · View at Google Scholar · View at Scopus
  88. F. L. M. Ricciardolo, P. Geppetti, A. Mistretta et al., “Randomised double-blind placebo-controlled study of the effect of inhibition of nitric oxide synthesis in bradykinin-induced asthma,” The Lancet, vol. 348, no. 9024, pp. 374–377, 1996. View at Publisher · View at Google Scholar · View at Scopus
  89. F. L. M. Ricciardolo, G. U. Di Maria, A. Mistretta, M. A. Sapienza, and P. Geppetti, “Impairment of bronchoprotection by nitric oxide in severe asthma,” The Lancet, vol. 350, no. 9087, pp. 1297–1298, 1997. View at Publisher · View at Google Scholar · View at Scopus
  90. P. N. Black and S. M. Brodie, “Nitric oxide and response to inhaled bradykinin in severe asthma,” The Lancet, vol. 351, no. 9100, pp. 449–450, 1998. View at Publisher · View at Google Scholar · View at Scopus
  91. S. Wolfrum, K. S. Jensen, and J. K. Liao, “Endothelium-dependent effects of statins,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 23, no. 5, pp. 729–736, 2003. View at Publisher · View at Google Scholar · View at Scopus
  92. U. Laufs and J. K. Liao, “Post-transcriptional regulation of endothelial nitric oxide synthase mRNA stability by Rho GTPase,” The Journal of Biological Chemistry, vol. 273, no. 37, pp. 24266–24271, 1998. View at Publisher · View at Google Scholar · View at Scopus
  93. O. Feron, C. Dessy, J.-P. Desager, and J.-L. Balligand, “Hydroxy-methylglutaryl-coenzyme A reductase inhibition promotes endothelial nitric oxide synthase activation through a decrease caveolin abundance,” Circulation, vol. 103, no. 1, pp. 113–118, 2001. View at Publisher · View at Google Scholar · View at Scopus
  94. C. Antoniades, M. Demosthenous, D. Tousouliset et al., “Role of asymmetrical dimethyl arginine in inflammation-induced endothelial dysfunction in human atherosclerosis,” Hypertension, vol. 58, no. 1, pp. 93–98, 2011. View at Google Scholar
  95. C. Y. Ivashchenko, B. T. Bradley, Z. Ao, J. Leiper, P. Vallance, and D. G. Johns, “Regulation of the ADMA-DDAH system in endothelial cells: a novel mechanism for the sterol response element binding proteins, SREBP1c and -2,” American Journal of Physiology—Heart and Circulatory Physiology, vol. 298, no. 1, pp. H251–H258, 2010. View at Publisher · View at Google Scholar · View at Scopus
  96. H. Matsuno, M. Takei, H. Hayashi, K. Nakajima, A. Ishisaki, and O. Kozawa, “Simvastatin enhances the regeneration of endothelial cells via VEGF secretion in injured arteries,” Journal of Cardiovascular Pharmacology, vol. 43, no. 3, pp. 333–340, 2004. View at Publisher · View at Google Scholar · View at Scopus
  97. D. Tousoulis, I. Andreou, M. Tsiatas et al., “Effects of rosuvastatin and allopurinol on circulating endothelial progenitor cells in patients with congestive heart failure: the impact of inflammatory process and oxidative stress,” Atherosclerosis, vol. 214, no. 1, pp. 151–157, 2011. View at Publisher · View at Google Scholar · View at Scopus
  98. M. Ortego, C. Bustos, M. A. Hernández-Presa et al., “Atorvastatin reduces NF-κB activation and chemokine expression in vascular smooth muscle cells and mononuclear cells,” Atherosclerosis, vol. 147, no. 2, pp. 253–261, 1999. View at Publisher · View at Google Scholar · View at Scopus
  99. M. Rupérez, R. Rodrigues-Díez, L. M. Blanco-Colio et al., “HMG-CoA reductase inhibitors decrease angiotensin II-induced vascular fibrosis: role of RhoA/ROCK and MAPK pathways,” Hypertension, vol. 50, no. 2, pp. 377–383, 2007. View at Publisher · View at Google Scholar · View at Scopus
  100. T. Terano, T. Shiina, Y. Noguchi et al., “Geranylgeranylpyrophosphate plays a key role for the G1 to S transition in vascular smooth muscle cells,” Journal of Atherosclerosis and Thrombosis, vol. 5, no. 1, pp. 1–6, 1998. View at Publisher · View at Google Scholar · View at Scopus
  101. M. E. Poynter, “Airway epithelial regulation of allergic sensitization in asthma,” Pulmonary Pharmacology & Therapeutics, vol. 25, no. 6, pp. 438–446, 2012. View at Publisher · View at Google Scholar · View at Scopus
  102. D. Proud and R. Leigh, “Epithelial cells and airway diseases,” Immunological Reviews, vol. 242, no. 1, pp. 186–204, 2011. View at Publisher · View at Google Scholar · View at Scopus
  103. M. E. Rothenberg and S. P. Hogan, “The eosinophil,” Annual Review of Immunology, vol. 24, pp. 147–174, 2006. View at Publisher · View at Google Scholar · View at Scopus
  104. Y.-M. Kim, Y.-S. Kim, S. G. Jeon, and Y.-K. Kim, “Immunopathogenesis of allergic asthma: more than the Th2 hypothesis,” Allergy, Asthma and Immunology Research, vol. 5, no. 4, pp. 189–196, 2013. View at Publisher · View at Google Scholar · View at Scopus
  105. L. Chen, K. A. Grabowski, J.-P. Xin et al., “IL-4 induces differentiation and expansion of Th2 cytokine-producing eosinophils,” Journal of Immunology, vol. 172, no. 4, pp. 2059–2066, 2004. View at Publisher · View at Google Scholar · View at Scopus
  106. J. C. Kips, “Cytokines in asthma,” European Respiratory Journal Supplement, vol. 18, no. 34, pp. 24s–33s, 2001. View at Publisher · View at Google Scholar · View at Scopus
  107. H. Tanaka, M. Komai, K. Nagao et al., “Role of interleukin-5 and eosinophils in allergen-induced airway remodeling in mice,” American Journal of Respiratory Cell and Molecular Biology, vol. 31, no. 1, pp. 62–68, 2004. View at Publisher · View at Google Scholar · View at Scopus
  108. M. Ostroukhova, R. W. Kouides, and E. Friedman, “The effect of statin therapy on allergic patients with asthma,” Annals of Allergy, Asthma and Immunology, vol. 103, no. 6, pp. 463–468, 2009. View at Publisher · View at Google Scholar · View at Scopus
  109. O. Pagovich, E. Wang, and M. Lee-Wong, “Statins may improve asthma,” Journal of Allergy and Clinical Immunology, vol. 125, no. 2, p. AB45, 2010. View at Publisher · View at Google Scholar
  110. R. Adams, S. Appleton, D. Wilson, and R. Ruffin, “Effects of lipid lowering therapy in a representative asthma population,” Respirology, vol. 15, p. A46, 2010. View at Google Scholar
  111. A. A. Zeki, J. Oldham, M. Wilson et al., “Statin use and asthma control in patients with severe asthma,” British Medical Journal Open, vol. 3, no. 8, Article ID e003314, 2013. View at Publisher · View at Google Scholar · View at Scopus
  112. G. Braganza, R. Chaudhuri, C. McSharry et al., “Effects of short-term treatment with atorvastatin in smokers with asthma—a randomized controlled trial,” BMC Pulmonary Medicine, vol. 11, article 16, 2011. View at Publisher · View at Google Scholar · View at Scopus
  113. D. Menzies, A. Nair, K. T. Meldrum, D. Fleming, M. Barnes, and B. J. Lipworth, “Simvastatin does not exhibit therapeutic anti-inflammatory effects in asthma,” Journal of Allergy and Clinical Immunology, vol. 119, no. 2, pp. 328–335, 2007. View at Publisher · View at Google Scholar · View at Scopus
  114. E. J. Hothersall, R. Chaudhuri, C. McSharry et al., “Effects of atorvastatin added to inhaled corticosteroids on lung function and sputum cell counts in atopic asthma,” Thorax, vol. 63, no. 12, pp. 1070–1075, 2008. View at Publisher · View at Google Scholar · View at Scopus
  115. D. C. Cowan, J. O. Cowan, R. Palmay, A. Williamson, and D. R. Taylor, “Simvastatin in the treatment of asthma: lack of steroid-sparing effect,” Thorax, vol. 65, no. 10, pp. 891–896, 2010. View at Publisher · View at Google Scholar · View at Scopus
  116. S. Foumani, F. Nejatifar, P. K. Forghan, S. Heidarinejad, and G. Mortazhejri, “Effects of atorvastatin in asthmatic patients under treatment with high dose inhaled or oral steroid [abstract],” in Proceedings of the European Respiratory Society Annual Congress, p. 372, Barcelona, Spain, September 2010.
  117. F. Fahimi, H. Jamaati, Z. M. Taheri, A. Fakharian, and J. Salamzadeh, “Does atorvastatin have effect on lung function and morbidity as add on therapy in asthmatic patients?” European Respiratory Journal, vol. 490, p. 2960, 2007. View at Google Scholar
  118. Y. Feschenko, L. Lashyna, N. Kramarskaya, M. Polianska, and J. Matvienko, “Clinical and functional effectiveness of atorvastatin in complex therapy of severe bronchial asthma [abstract],” in Proceedings of the European Respiratory Society Annual Congress, [E4554], Berlin, Germany, October 2009.
  119. A. Moini, G. Azimi, and A. Farivar, “Evaluation of atorvastatin for the treatment of patients with asthma: a double-blind randomized clinical trial,” Allergy, Asthma and Immunology Research, vol. 4, no. 5, pp. 290–294, 2012. View at Publisher · View at Google Scholar · View at Scopus
  120. K. Maneechotesuwan, W. Ekjiratrakul, K. Kasetsinsombat, A. Wongkajornsilp, and P. J. Barnes, “Statins enhance the anti-inflammatory effects of inhaled corticosteroids in asthmatic patients through increased induction of indoleamine 2, 3-dioxygenase,” Journal of Allergy and Clinical Immunology, vol. 126, no. 4, pp. 754–762, 2010. View at Publisher · View at Google Scholar · View at Scopus
  121. A. A. Zeki, “Statins and asthma: where we stand, and the next critical steps in research,” Current Medical Research & Opinion, vol. 30, no. 6, pp. 1051–1054, 2014. View at Publisher · View at Google Scholar · View at Scopus
  122. S. E. Alexeeff, A. A. Litonjua, D. Sparrow, P. S. Vokonas, and J. Schwartz, “Statin use reduces decline in lung function: VA normative aging study,” American Journal of Respiratory and Critical Care Medicine, vol. 176, no. 8, pp. 742–747, 2007. View at Publisher · View at Google Scholar · View at Scopus
  123. J. I. Keddissi, W. G. Younis, E. A. Chbeir, N. N. Daher, T. A. Dernaika, and G. T. Kinasewitz, “The use of statins and lung function in current and former smokers,” Chest, vol. 132, no. 6, pp. 1764–1771, 2007. View at Publisher · View at Google Scholar · View at Scopus
  124. N. C. Thomson and R. Chaudhuri, “Asthma in smokers: challenges and opportunities,” Current Opinion in Pulmonary Medicine, vol. 15, no. 1, pp. 39–45, 2009. View at Publisher · View at Google Scholar · View at Scopus
  125. A. A. Zeki, J. M. Bratt, K. Y. Chang et al., “Intratracheal instillation of pravastatin for the treatment of murine allergic asthma: a lung-targeted approach to deliver statins,” Physiological Reports, vol. 3, no. 5, Article ID e12352, 2015. View at Publisher · View at Google Scholar
  126. L. Xu, X.-W. Dong, L.-L. Shen et al., “Simvastatin delivery via inhalation attenuates airway inflammation in a murine model of asthma,” International Immunopharmacology, vol. 12, no. 4, pp. 556–564, 2012. View at Publisher · View at Google Scholar · View at Scopus
  127. Group Health Co-Operative, Atherosclerotic Cardiovascular Disease Primary Prevention Guideline, Group Health Co-Operative, 2014.
  128. A. C. Knapp, J. Huang, G. Starling, and P. A. Kiener, “Inhibitors of HMG-CoA reductase sensitize human smooth muscle cells to Fas-ligand and cytokine-induced cell death,” Atherosclerosis, vol. 152, no. 1, pp. 217–227, 2000. View at Publisher · View at Google Scholar · View at Scopus
  129. P. A. Kiener, P. M. Davis, J. L. Murray, S. Youssef, B. M. Rankin, and M. Kowala, “Stimulation of inflammatory responses in vitro and in vivo by lipophilic HMG-CoA reductase inhibitors,” International Immunopharmacology, vol. 1, no. 1, pp. 105–118, 2001. View at Publisher · View at Google Scholar · View at Scopus
  130. U. Ikeda and K. Shimada, “Statins and monocytes,” The Lancet, vol. 353, no. 9169, p. 2070, 1999. View at Google Scholar · View at Scopus
  131. D. Ferro, S. Parrotto, S. Basili, C. Alessandri, and F. Violi, “Simvastatin inhibits the monocyte expression of proinflammatory cytokines in patients with hypercholesterolemia,” Journal of the American College of Cardiology, vol. 36, no. 2, pp. 427–431, 2000. View at Publisher · View at Google Scholar · View at Scopus
  132. O. Grip, S. Janciauskiene, and S. Lindgren, “Atorvastatin activates PPAR-γ and attenuates the inflammatory response in human monocytes,” Inflammation Research, vol. 51, no. 2, pp. 58–62, 2002. View at Publisher · View at Google Scholar · View at Scopus
  133. H. K. Takahashi, S. Mori, H. Iwagaki et al., “Differential effect of LFA703, pravastatin, and fluvastatin on production of IL-18 and expression of ICAM-1 and CD40 in human monocytes,” Journal of Leukocyte Biology, vol. 77, no. 3, pp. 400–407, 2005. View at Publisher · View at Google Scholar · View at Scopus
  134. R. S. Rosenson, C. C. Tangney, and L. C. Casey, “Inhibition of proinflammatory cytokine production by pravastatin,” The Lancet, vol. 353, no. 9157, pp. 983–984, 1999. View at Google Scholar · View at Scopus
  135. A. H. Wagner, O. Schwabe, and M. Hecker, “Atorvastatin inhibition of cytokine-inducible nitric oxide synthase expression in native endothelial cells in situ,” British Journal of Pharmacology, vol. 136, no. 1, pp. 143–149, 2002. View at Publisher · View at Google Scholar · View at Scopus
  136. T. Fehr, C. Kahlert, W. Fierz et al., “Statin-induced immunomodulatory effects on human T cells in vivo,” Atherosclerosis, vol. 175, no. 1, pp. 83–90, 2004. View at Publisher · View at Google Scholar · View at Scopus
  137. R. A. Neese, L. M. Misell, S. Turner et al., “Measurement in vivo of proliferation rates of slow turnover cells by 2H2O labeling of the deoxyribose moiety of DNA,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 24, pp. 15345–15350, 2002. View at Publisher · View at Google Scholar · View at Scopus
  138. A. Chu, E. T. Ordonez, and M. K. Hellerstein, “Measurement of mouse vascular smooth muscle and atheroma cell proliferation by 2H2O incorporation into DNA,” American Journal of Physiology—Cell Physiology, vol. 291, no. 5, pp. C1014–C1021, 2006. View at Publisher · View at Google Scholar · View at Scopus
  139. N. C. Thomson, C. E. Charron, R. Chaudhuri, M. Spears, K. Ito, and C. McSharry, “Atorvastatin in combination with inhaled beclometasone modulates inflammatory sputum mediators in smokers with asthma,” Pulmonary Pharmacology & Therapeutics, vol. 31, pp. 1–8, 2015. View at Publisher · View at Google Scholar
  140. Global Initiative for Asthma, Global Strategy for Asthma Management and Prevention, 2014, http://www.ginasthma.org/.
  141. K. Maneechotesuwan, K. Kasetsinsombat, V. Wamanuttajinda, A. Wongkajornsilp, and P. J. Barnes, “Statins enhance the effects of corticosteroids on the balance between regulatory T cells and Th17 cells,” Clinical and Experimental Allergy, vol. 43, no. 2, pp. 212–222, 2013. View at Publisher · View at Google Scholar · View at Scopus